We are live on ! Find out more
RLWM

RF&L Wealth Management Portfolio holdings

AUM $148M
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+8.67%
1 Year Est. Return
+23.72%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$130M
AUM Growth
+$9.54M
Cap. Flow
+$194K
Cap. Flow %
0.15%
Top 10 Hldgs %
57.69%
Holding
57
New
2
Increased
17
Reduced
18
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 9.75%
2 Healthcare 5.92%
3 Consumer Discretionary 3.72%
4 Consumer Staples 3.39%
5 Communication Services 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPE icon
51
Xtrackers S&P 500 ESG ETF
SNPE
$2.54B
$225K 0.17%
4,697
FXL icon
52
First Trust Technology AlphaDEX Fund
FXL
$2.4B
$219K 0.17%
1,625
GOOGL icon
53
Alphabet (Google) Class A
GOOGL
$4.12T
$215K 0.17%
+1,423
New +$204K
PG icon
54
Procter & Gamble
PG
$340B
$215K 0.17%
+1,322
New +$207K
TSLA icon
55
Tesla
TSLA
$1.18T
$204K 0.16%
1,158
RVNC
56
DELISTED
Revance Therapeutics, Inc.
RVNC
$162K 0.13%
33,000
PFE icon
57
Pfizer
PFE
$143B
-7,220
Closed -$208K

Similar funds

RF&L Wealth Management's Q1 2024 Portfolio in Review

As of Q1 2024, RF&L Wealth Management held 57 positions worth $130M, up 7.9% from $120M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

RF&L Wealth Management's Q1 2024 filing shows 2 new, 17 increased, 18 reduced and 1 closed positions. Its largest new stake was Procter & Gamble: 1,322 shares worth $215K. The largest sale was Dimensional US Marketwide Value ETF, an estimated $367K.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • RF&L Wealth Management's largest Q1 2024 buy was Procter & Gamble: 1,322 shares worth $215K.
  • RF&L Wealth Management added most to Vanguard Short-Term Bond ETF in Q1 2024, an estimated $393K increase.
  • RF&L Wealth Management's biggest Q1 2024 reduction was Dimensional US Marketwide Value ETF, cutting an estimated $367K.
  • RF&L Wealth Management fully exited Pfizer in Q1 2024, selling an estimated $208K.
  • RF&L Wealth Management's ten largest holdings make up 58% of its $130M portfolio in Q1 2024.
  • RF&L Wealth Management opened 2 new positions and closed 1 in Q1 2024.
  • RF&L Wealth Management's portfolio value rose 7.9% quarter-over-quarter to $130M.

Based on RF&L Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.